Literature DB >> 11569761

Time is on my side: optimism in intertemporal choice.

M Berndsen1, J van der Pligt.   

Abstract

The present research examines the role of optimism on time preferences for both losses and gains. It is argued that optimism has asymmetric effects on time preferences for gains versus losses: one reason why decision makers prefer immediate gains is because they are optimistic that these gains will be followed by additional gains in future. In contrast, decision makers prefer to delay losses because they are optimistic that losses are avoidable in the future. Optimism about outcomes affects time preferences for both gains and losses, such that low optimism reduces the discount rates while increased optimism is associated with higher discount rates. This prediction was supported in two different domains: monetary outcomes (Study 1), and health (Study 2). Implications of these results for both research practice and time preferences in the real world are discussed.

Mesh:

Year:  2001        PMID: 11569761     DOI: 10.1016/s0001-6918(01)00029-4

Source DB:  PubMed          Journal:  Acta Psychol (Amst)        ISSN: 0001-6918


  5 in total

1.  Differential time preferences for money and quality of life.

Authors:  M B Y Parouty; H H Le; D Krooshof; M J Postma
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

2.  Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting.

Authors:  Henry Lin; Leonard H Epstein
Journal:  Behav Neurosci       Date:  2014-02       Impact factor: 1.912

3.  Behavioral trainings and manipulations to reduce delay discounting: A systematic review.

Authors:  Hanneke Scholten; Anouk Scheres; Erik de Water; Uta Graf; Isabela Granic; Maartje Luijten
Journal:  Psychon Bull Rev       Date:  2019-12

4.  Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP): a protocol for a pragmatic, multicentre, observer-blinded, 12-month randomised controlled study.

Authors:  Muke Zhou; Jian Guo; Ning Chen; Mengmeng Ma; Shuju Dong; Yanbo Li; Jinghuan Fang; Yang Zhang; Yanan Zhang; Jiajia Bao; Ye Hong; You Lu; Mingfang Qin; Ling Yin; Xiaodong Yang; Quan He; Xianbin Ding; Liyan Chen; Zhuoqun Wang; Shengquan Mi; Shengyun Chen; Cairong Zhu; Dong Zhou; Li He
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

5.  Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis.

Authors:  Monica Ortendahl
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.